This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Glucose-lowering medications and comparative kidney outcomes in type 2 diabetes

  • Sodium–glucose cotransporter 2 inhibitors in heart failure: does it matter how they work?

  • EMPA-VISION: Cardiac energy in people with heart failure taking empagliflozin

  • The safety of sodium–glucose cotransporter-2 inhibitors in people with chronic kidney disease and type 2 diabetes

    The safety of sodium–glucose cotransporter-2 inhibitors in people with chronic kidney disease and type 2 diabetes

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe